Polymorphic Basal Rates of Continuous Subcutaneous Insulin Infusion among Taiwanese Children with Type 1 Diabetes

Table 1

Patient characteristics and daily insulin requirement by Tanner stage group before continuous subcutaneous insulin infusion (CSII) therapy.

	All stages	Stage 1 or 2	Stage 3 or 4	Stage 5	Young adult (>18 years old)
	45	9	10	18	8
Girl (%)	58	33	60	67	63	0.410
Height (cm)	155.7 ± 11.8	144.2 ± 8.3	149.4 ± 8.4	160.8 ± 8.4	165.4 ± 11.6	<0.001^*
Height-SDS	0.24 ± 0.17	0.27 ± 1.02	0.36 ± 1.37	0.15 ± 0.97	0.25 ± 1.37	0.972
Weight (kg)	47.1 ± 10.9	37.4 ± 7.9	39.3 ± 5.9	50.5 ± 7.7	60.1 ± 7.7	<0.001^*
Weight-SDS	−0.12 ± 0.68	−0.12 ± 0.99	−0.22 ± 0.85	−0.26 ± 0.33	0.29 ± 0.61	0.276
BMI (kg/m^2)	19.2 ± 2.6	18.0 ± 3.1	17.5 ± 1.7	19.5 ± 1.9	22.0 ± 2.1	<0.001^*
BMI-SDS	−0.24 ± 0.65	−0.24 ± 0.93	−0.43 ± 0.61	−0.34 ± 0.42	0.22 ± 0.70	0.156
T1D duration (years)	5.3 ± 4.1	3.7 ± 3.6	3.4 ± 3.0	5.9 ± 3.9	8.1 ± 4.9	0.050
HbA1c (mmol/mol)	67 ± 30	51 ± 8	79 ± 52	66 ± 26	73 ± 10	0.221
HbA1c (%)	8.3 ± 2.8	6.8 ± 0.8	9.3 ± 4.7	8.2 ± 2.4	8.9 ± 0.9	0.221

Data are mean ± standard deviation or percentage. ^*Significant difference () by ANOVA test.